Prospect Capital (PSEC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
8 Jan, 2026Executive summary
Adjourned annual meeting held on January 8, 2026, with continuation scheduled for January 15, 2026, to allow more time for soliciting shareholder votes on proposals described in the proxy statement.
Prospect Capital focuses on lending to and investing in middle market privately-held companies, aiming for current income and long-term capital appreciation.
Forward-looking statements are subject to significant uncertainties and are not guarantees of future performance.
Voting matters and shareholder proposals
Proposals for the annual meeting are detailed in the definitive proxy statement filed on September 18, 2025.
Each share of common and preferred stock is entitled to one vote on each matter relevant to its class.
The meeting was adjourned to provide additional time for vote solicitation on the proposal.
Shareholder rights and capital structure
As of September 17, 2025, there were over 465 million shares of common stock and multiple series of preferred stock outstanding, each with specific voting rights.
Latest events from Prospect Capital
- Proposal seeks renewed authority to sell common stock below NAV, with Board support and dilution risks.PSEC
Proxy Filing11 Mar 2026 - Shareholders are asked to approve limited sales of stock below net asset value for the next year.PSEC
Proxy Filing11 Mar 2026 - Robust middle-market lender with strong returns, low risk, and disciplined financial management.PSEC
Investor presentation2 Mar 2026 - Shareholders are asked to renew approval for below-NAV stock sales, capped at 25% per sale.PSEC
Proxy Filing27 Feb 2026 - Net investment income was $91M, NAV per share $6.21, and first lien loan exposure increased.PSEC
Q2 202610 Feb 2026 - Net investment income was $102.9M, NAV $8.74, and the 86th straight dividend was declared.PSEC
Q4 202422 Jan 2026 - Net investment income fell as NAV declined and the portfolio shifted to first-lien loans.PSEC
Q1 202515 Jan 2026 - NII was $86.4M, NAV per share $7.84, with strong liquidity and low non-accruals at 0.4%.PSEC
Q2 202523 Dec 2025 - Annual meeting adjourned to January 8, 2026, to solicit more votes on a key proposal.PSEC
Proxy Filing16 Dec 2025